Douglas Middleton Dahl, M.D.
This page shows the publications co-authored by Douglas Dahl and Mark Preston.
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol. 2016 08 10; 34(23):2705-11.
Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urol Oncol. 2015 Sep; 33(9):383.e9-16.
Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years. J Urol. 2019 04; 201(4):721-727.
Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance. AJR Am J Roentgenol. 2016 Oct; 207(4):789-796.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.